<DOC>
	<DOCNO>NCT02263456</DOCNO>
	<brief_summary>The purpose study : - compare pharmacokinetics Replenine®-VF Replenine® high purity Factor IX concentrate , give bolus dose 75IU/kg . - compare 1st 2nd pharmacokinetic assessment Replenine®-VF ( conduct 3 month apart ) recovery patient change batch . - evaluate Replenine®-VF term clinical tolerance safety patient severe haemophilia B .</brief_summary>
	<brief_title>A Study Compare Pharmacokinetics Safety Replenine®-VF , Replenine® Other Factor IX Haemophilia B</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Patients age 12 year At least 20 exposure suffer severe Haemophilia B without inhibitor Factor IX Replenine® high purity Factor IX product</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>